AZD0364 is primarily researched for its potential therapeutic applications in the treatment of various cancers. It functions as a selective inhibitor, targeting specific pathways involved in tumor growth and progression. By inhibiting these pathways, it may help in reducing the proliferation of cancer cells and inducing apoptosis, making it a promising candidate for oncology drug development. Its application is currently under clinical investigation to evaluate its efficacy and safety in patients with certain types of malignancies. Additionally, it is being studied for its potential to overcome resistance to other cancer therapies, offering a new approach to treatment in challenging cases.